Astrazeneca Plc (AZN)
$53.11 2.11 (3.82%)
19:57 EDT AZN Stock Quote Delayed 30 Minutes
Previous Close $53.11
Market Cap 134.54B
PE Ratio 47.94
Volume (Avg. Vol.) 5.63M
Day's Range 53.10 - 54.59
52-Week Range 36.15 - 57.44
Dividend & Yield 1.37 (2.58%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
- From InvestorPlace
- From the Web
AstraZeneca Plc (NYSE:AZN) is ranked as a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. The shares have been upgraded from a Hold to a Buy in the last week.
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Hold. Using Louis Navellier's investing methodology, this analytical tool assesses stocks with fundamental and quantitative analytical tools. AZN has maintained this ranking for the last month.
AstraZeneca Plc (NYSE:AZN) is a component of the 135 company Pharmaceuticals GICS industry group, which is a segment of the 783 company GICS Health Care sector. AZN's market value is $87.6 billion which falls in the top decile in its industry group. The ranking for AZN by Portfolio Grader places it 49 among the 135 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 301 among the 783 companies in the sector, and number 2,076 in the nearly 5,000 company Portfolio Grader universe.
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for the last month.
Currently, AstraZeneca Plc (NYSE:AZN) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. AZN has maintained this ranking for 2 months.
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc. (IPI) and Marathon Oil Corporation (MRO) Are 3 of Today’s Worst Stocks
Marathon Oil (MRO), Teva Pharmaceutical Industries (TEVA) and Intrepid Potash (IPI) shareholders should have made it a three-day weekend.
TEVA stock is in the spotlight again when it reports quarterly results this week. Teva Pharmaceutical investors will look closely at cash flow and debt.
Why AstraZeneca plc (ADR) (AZN), Advanced Micro Devices, Inc. (AMD) and Spirit Airlines Incorporated (SAVE) Are 3 of Today’s Worst Stocks
Advanced Micro Devices (AMD), AstraZeneca (AZN) and Spirit Airlines (SAVE) never even had a prayer of bullish progress on Thursday.
Bristol-Myers Squibb (BMY) stock took a hit today after AstraZeneca (AZN) reported a failed drug test, despite its positive earnings report.
AstraZeneca(AZN) stock was hit hard Thursday after its new lung cancer drug failed to meet a primary endpoint in a Phase III trial.
Why Cyberark Software Ltd (CYBR), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Wynn Resorts, Limited (WYNN) Are 3 of Today’s Worst Stocks
Teva Pharmaceutical (TEVA), Wynn Resorts (WYNN) and Cyberark Software (CYBR) shareholders couldn't wait for the trading week to end.
Investors have been relatively complacent, but it's only a matter of time before anxiety strikes again. And these stocks could go either way.
AstraZeneca (AZN) stock was up on Friday following positive results in a Phase III trial for its lung cancer drug Imfinzi.
3 Big Charts for Friday: Tiffany & Co. (TIF), J C Penney Company Inc (JCP) and AstraZeneca plc (ADR) (AZN)
JC Penney (JCP) stock dips into technical no-man's land, while Tiffany (TIF) and AstraZeneca (AZN) are attracting technical buyers.
Valeant earnings are due out Tuesday morning, but it would take a laundry list of good news to sustain the rally in VRX stock.
Paris, France based Sanofi (SNY) is a global healthcare company possessing a diversified product portfolio.
Tesaro (TSRO) climbed Tuesday on an FDA approval, but possible side effects and lack of price info have dampened the parade in TSRO stock.
Fans of dividends don't have to completely abandon all hope for growth too -- these top pharmaceutical stocks offer the best of both worlds.
From Simply Wall St
Chegg, Inc. (NYSE:CHGG), which is in the consumer services business, and is based in United States, received a lot of attention from a substantial price increase on the NYSE over<div><a class="permalink" href="https://simplywall.st/stocks/us/consumer-services/nyse-chgg/chegg/news/is-now-the-time-to-look-at-buying-chegg-inc-nysechgg/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader